Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
暂无分享,去创建一个
R. Virmani | A. Finn | F. Kolodgie | Qi Cheng | A. Cornelissen | Liang Guo | H. Jinnouchi | Yu Sato | A. Sakamoto | Matthew D. Kutyna | S. Tunev | Christine Jennifer | R. Wijeratne | Y. Sato | Rashmi Wijeratne
[1] M. Price,et al. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. , 2020, The New England journal of medicine.
[2] R. Virmani,et al. Drug-eluting coronary stents: insights from preclinical and pathology studies , 2019, Nature Reviews Cardiology.
[3] H. Okayama,et al. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. , 2019, JAMA.
[4] R. Virmani,et al. Thromboresistance and Functional Healing in the COBRA PzF Stent versus Competitor DES: Implications for Dual Anti-Platelet Therapy. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] M. Stoel,et al. Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial , 2018, The Lancet.
[6] W. Desmet,et al. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis , 2017, Circulation.
[7] M. Stoel,et al. Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial , 2017, JAMA cardiology.
[8] Laura Mauri,et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.
[9] F. Eberli,et al. Polymer-free Drug-Coated Coronary Stents. , 2016, The New England journal of medicine.
[10] J. Hirsh,et al. Medical device‐induced thrombosis: what causes it and how can we prevent it? , 2015, Journal of thrombosis and haemostasis : JTH.
[11] Samin K. Sharma,et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. , 2015, Journal of the American College of Cardiology.
[12] A. Finn,et al. Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration. , 2015, Pharmacological research.
[13] A. Finn,et al. Sirolimus-FKBP12.6 Impairs Endothelial Barrier Function Through Protein Kinase C-&agr; Activation and Disruption of the p120–Vascular Endothelial Cadherin Interaction , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[14] R. Latour,et al. The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding. , 2010, Biomaterials.
[15] A. Hotta,et al. Fluorine doping into diamond-like carbon coatings inhibits protein adsorption and platelet activation. , 2007, Journal of biomedical materials research. Part A.
[16] E. Edelman,et al. Cardiology is flow. , 2006, Circulation.
[17] A. Malik,et al. Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.
[18] R. Virmani,et al. Drug eluting stents: are human and animal studies comparable? , 2003, Heart.
[19] M. Corada,et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Edelman,et al. Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.
[21] J M Courtney,et al. Biomaterials for blood-contacting applications. , 1994, Biomaterials.
[22] D. Lyman,et al. The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. III. In vivo adsorption of proteins on polymer surfaces. , 1974, Transactions - American Society for Artificial Internal Organs.